Donor Nephrectomy Clinical Trial
— HAPERPACTOfficial title:
Hand-Assisted Laparoscopic Donor Nephrectomy PERiumbilical Versus Pfannenstiel Incision and Return to Normal Physical ACTivity: A Randomized Clinical Trial: HAPERPACT Trial
Despite efforts to optimize the transplantation of deceased donor kidneys, the number of available kidneys continues to fall short of the demand. Living donor kidneys have been used to overcome this shortage. Graft and patient survival is significantly higher following living donor kidney transplantation compared with deceased donor kidney transplantation. Open donor nephrectomy was the universal technique prior to the advent of laparoscopic techniques. Laparoscopic approaches have definite advantages over open surgery in terms of blood loss, postoperative pain, analgesic requirements, duration of hospital stay, and convalescence. There is some controversy regarding longer warm ischemia time, longer operative time, and increased bleeding with laparoscopic nephrectomy compared with hand-assisted laparoscopic living donor nephrectomy (HALDN). HALDN attempted to reduce warm ischemia time by using the hand port to extract the kidney instantly after dividing the blood vessels. This technique also offers tactile feedback, better manual control of bleeding, a relatively shorter learning curve, less kidney traction, faster kidney removal, and shorter warm ischemic periods. HALDN is often performed using periumbilical and Pfannenstiel incisions for hand-assisted port placement. Pfannenstiel incisions improve wound complications such as incisional hernia, cosmetic issues, and wound dehiscence. However, duration of surgery, postoperative pain score, and length of hospital stay are significantly lower in donors with periumbilical incisions.To the best of our knowledge, these two types of incision have not been compared in a randomized controlled trial in patients undergoing HALDN. Our objective is to compare the results of Pfannenstiel incision (intervention group) with periumbilical incision (control group). The return to normal physical activity will be evaluated in a clinical randomized trial using an expertise-based design.
Status | Recruiting |
Enrollment | 52 |
Est. completion date | June 1, 2020 |
Est. primary completion date | February 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Age > 20 years - No permanent pain therapy - Kidneys with only a single artery and vein in the graft - Informed consent for participation provided Exclusion Criteria: - Infection or scar present precluding incision placement at one of the randomization sites - Bleeding disorders - Chronic use of immunosuppressive agents (e.g. steroids) |
Country | Name | City | State |
---|---|---|---|
Germany | Division of Visceral Transplantation, Department of General, Visceral and Transplantation Surgery, University of Heidelberg | Heidelberg | Baden-Württemberg |
Lead Sponsor | Collaborator |
---|---|
University Hospital Heidelberg |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Days to return to normal physical activity | Patients will be asked to complete the "Katz basic activities of daily living" self-maintenance questionnaire each day for 4 weeks after the operation. This questionnaire assesses the ability to perform daily living activities (0 = no activity and 6 = normal activity). The normal physical activity is perceived as good. | Four weeks | |
Secondary | Warm ischemia time | From the time of clamping of the first renal artery in situ to flushing of the kidney with chilled solution on the back table | One day | |
Secondary | Intraoperative complications | From skin incision to skin closure | One day | |
Secondary | Estimated blood loss | From skin incision to skin closure | One day | |
Secondary | Operating time | From skin incision to skin closure | One day | |
Secondary | Postoperative pain | Severity of pain via 11-point Visual Analogue Scale (0 = no pain and 10 = unbearable distress). | Seven days | |
Secondary | Rescue analgesic | Total amount of analgesics required. | Seven days | |
Secondary | Peak expiratory flow rate | Is defined as maximum speed of expiration, as measured with a peak flow meter. | Seven days | |
Secondary | Postoperative complications | According to the Clavien-Dindo classification | 60 days | |
Secondary | Length of hospital stay | From the day of the operation until the day of discharge | 60 days | |
Secondary | Time to return to work | From the day of discharge and return to work | 60 days | |
Secondary | Physical activity score | The International Physical Activity Questionnaire, Short Form (IPAQ) will be used as an indicator of physical activity and fitness. IPAQ assesses total physical activity in the previous 7 days. Questions measure the frequency (days per week) and duration (minutes per session) of physical activity, as well as its intensity level (vigorous, moderate, walking, or sitting). Participants are categorized into one of three physical activity levels (low, moderate, high). Range is not applicable because it is a categorical variable. The high activity category is perceived as good. | 60 days | |
Secondary | Patient satisfaction | Patient satisfaction score via 5-point Likert scale (5 = representing strongly satisfied and 1 = representing strongly unsatisfied). | 60 days | |
Secondary | Cosmetic score | As defined by the Stony Brook scar scale (SBSES). The SBSES assessed five scar components: width, height, color, suture marks and overall appearance. Each component was assigned a score of 0 or 1 with a total sum range of 0 (worst) to 5 (best). | 60 days | |
Secondary | Incisional hernia | Defined as a fascia or muscle defect (bulging hernial sac and palpable fascia gap) at the site of the surgical incision examined by palpation and ultrasonography. | 60 days | |
Secondary | Mortality | Death due to any cause. | 60 days | |
Secondary | Recipient serum creatinine level | Serum creatinine level (mg/dL) | 30 days | |
Secondary | Glomerular filtration rate | GFR (mL/min/1.73 m2) calculated with "175 × (Scr)-1.154 × (Age)-0.203 × (0.742 if female)" Formula | 30 days | |
Secondary | Delayed graft function | Is defined as the need for one or more hemodialysis treatments following transplantation prior to the onset of graft function. | 30 days | |
Secondary | Primary non-function | A recipient whose graft never functions. | 30 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01925677 -
Robotic Single Port Donor Nephrectomy
|
N/A |